Back to Journals » Cancer Management and Research » Volume 11

The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis

Total article views   Abstract views HTML views PDF downloads Totals
1,040 Dovepress* 895 85+ 417 980
PubMed Central* 0 60 32 60
Totals 895 145 449 1,040
*Since 7 May 2019
+Since July 2016

View citations on PubMed Central and Google Scholar